Insider: Whitfield Dianne C. Chief Human Resources Officer - Tarsus Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 35,028 | 0 | 35,028 |
| Value | $2,456,163.36 | $0.00 | $2,456,163.36 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/19/2026 | DDS | 4,174 | Direct | COM | $67.00 | $279,658.00 | 35,028 |
| 03/18/2026 | DDS | 4,071 | Direct | COM | $68.71 | $279,718.41 | 39,202 |
| 03/17/2026 | DDS | 4,029 | Direct | COM | $69.42 | $279,693.18 | 43,273 |
| 01/02/2026 | DDS | 8,122 | Direct | COM | $80.71 | $655,526.62 | 25,121 |
| 01/02/2026 | DDS | 5,715 | Direct | COM | $80.09 | $457,714.35 | 33,243 |
| 01/02/2026 | DDS | 835 | Direct | COM | $81.90 | $68,386.50 | 24,286 |
| 01/02/2026 | DDS | 893 | Direct | COM | $82.93 | $74,056.49 | 23,393 |
| 12/16/2025 | DDS | 7,397 | Direct | COM | $80.10 | $592,499.70 | 38,958 |
| 03/20/2025 | DDS | 2,137 | Direct | COM | $50.11 | $107,085.07 | 46,355 |
| 03/19/2025 | DDS | 2,259 | Direct | COM | $47.40 | $107,076.60 | 48,492 |
| 03/18/2025 | DDS | 2,315 | Direct | COM | $46.29 | $107,161.35 | 50,751 |
| 03/18/2024 | DDS | 4,314 | Direct | COM | $30.60 | $132,008.40 | 34,181 |
| 11/30/2023 | DDS | 8,355 | Direct | COM | $16.31 | $136,270.05 | 26,784 |
| 03/20/2023 | DDS | 333 | Direct | COM | $12.61 | $4,199.13 | 12,223 |
| 03/17/2023 | DDS | 316 | Direct | COM | $13.28 | $4,196.48 | 12,556 |
| 03/16/2023 | DDS | 313 | Direct | COM | $13.43 | $4,203.59 | 12,872 |
| 12/02/2022 | DDS | 1,154 | Direct | COM | $16.90 | $19,502.60 | 8,723 |
| 12/01/2022 | DDS | 1,165 | Direct | COM | $16.75 | $19,513.75 | 9,877 |
| 11/30/2022 | DDS | 1,182 | Direct | COM | $16.50 | $19,503.00 | 11,042 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research